It's likely NanoDX will be finalising another funding round shortly. Whether or not that occurs pre or post EUA approval we will have to see. However this can only be a good thing for Sensera and it will be interesting to see how much NanoDX will raise.
A reminder from the CEOCFO interview back in March with NanoDX CEO Sharad Joshi:
CEOCFO: Are you seeking funding, partnership and investment now?
Mr. Joshi: Yes, we are. We have been very lucky to partner with some great people out there in terms of license fields to bring in non-dilutive funding to our company. We have also closed the Series C during 2020 and we also are seeking some additionally investment to really scale to a larger volume right now and we are very close to closing that so we can execute on the larger plans. The volumes of product that we are planning on building today are about well over a hundred times greater than the volumes we were seeking to develop and manufacture just a year ago.
Regarding the below quote, I presume there is some inference to IBM as the collaboration agreement should allow NanoDX to really scale the product at huge volumes with a much lower cost.
CEOCFO: Where are you in the development and commercialization process?
Mr. Joshi: At this point, a large part of our development is behind us. Now we are manufacturing and developing manufacturing processes and scaling and improving our yield for those processes. As we improve those yields, we will be able to make more and more product. While the volumes for our ailments are very high, none are more urgent and important than that of COVID these days. We have a lot of interest and we are scaling tremendous amounts of manufacturing capability with our manufacturing partners to be able to bring this technology to more and more people.
Cheers
SE1 Price at posting:
4.0¢ Sentiment: Buy Disclosure: Held
